Enhancing Patient Engagement Efforts Across the FDA

 
The FDA is soliciting input on ongoing efforts to enhance mechanisms for patient engagement at the Agency. In this tradition, FDA intends to enhance future patient engagement by providing a more transparent, accessible, and robust experience for patient communities. To achieve these goals, FDA is considering establishing a new Office of Patient Affairs. This concept was directly informed by the public feedback solicited through the prior public docket regarding FDA’s stakeholder engagement responsibilities outlined by the FDA Safety and Innovation Act. The purpose of this notice is to outline FDA’s proposal for the future of patient engagement at the Agency so that the perspectives of patient communities can be better captured. Comments on this proposal are accepted through June 12, 2017.
To read more, please click here.

Assisted Outpatient Treatment in New York State: The Case for Making Kendra’s Law Permanent

Assisted outpatient treatment (AOT) is a procedure by which seriously mentally ill individuals are placed under a court-ordered treatment plan while continuing to live in the community. New York State’s version of AOT is known as “Kendra’s Law,” named after Kendra Webdale, a New York City resident pushed to her death in front of a subway train in 1999 by a man with untreated schizophrenia.
Kendra’s Law was enacted on a trial basis and has been temporarily reauthorized twice. It is up for reauthorization again during the current legislation session. Based on experience and extensive research, the state government should make the law permanent.
To read the report, please click here.

How this couple stopped mental illness from tearing them apart

San Francisco-based teacher Mark Lukach was married to his wife Giulia for just three years when she had her first psychotic episode at age 27. In the years that followed, he and Giulia and their young son, Jonas, learned how to cope with the terrifying psychosis, the crippling depression, recovery and relapses that cameRead More

[Continue reading…]

You Need To Be Watching What Is Happening In Washington: A Big Shift Maybe Coming

Texas Senator John Cornyn, the Republican majority whip in the Senate, is putting federal dollars behind his  Mental Health and Safe Communities Act, that was signed into law during the final days of the Obama administration. Because of the hoopla about Pennsylvania Republican Rep. Tim Murphy’s Helping Families in Mental Health Crisis Act, Cornyn’s legislationRead More

[Continue reading…]

ICYMI: Murphy on C-SPAN: Continuing the Fight for Families in Mental Health Crisis

On March 22, 2017, Congressman Murphy continued his fight for families in mental health crisis on C-SPAN’s Washington Journal. In case you missed it, check out the highlights and watch the full interview below.   Print PDF

[Continue reading…]

Estrogen Alters Memory Circuit Function in Women with Gene Variant

Hormone-gene interaction may underlie sex/individual differences in mental disorders Fluctuations in estrogen can trigger atypical functioning in a key brain memory circuit in women with a common version of a gene, NIMH scientists have discovered. Brain scans revealed altered circuit activity linked to changes in the sex hormone in women with the gene variant whileRead More

[Continue reading…]

Multipronged Study of Schizophrenia associated Syndrome Receives $3.1 Million NIH Grant

A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety. The research is funded by a $3.1 million grant from the NationalRead More

[Continue reading…]

Adjunctive VNS Improves Long-Term Outcomes in Treatment-Resistant Depression

Adjunctive vagus nerve stimulation (VNS) can lead to better five-year clinical outcomes in patients with chronic, treatment-resistant depression, reports a study published March 31 inAJP in Advance. These findings provide the first long-term evidence of the benefits of VNS. VNS, which involves delivering electrical impulses to the vagus nerve via an implanted generator, was approved for treatment-resistant depression inRead More

[Continue reading…]

Intellectual Disability Still a Bar to Death Penalty, Says Supreme Court

The U.S. Supreme Court on March 28 reaffirmed that intellectual disability is a constitutional barrier to the death penalty. The ruling in the case of Moore v. Texas upheld two previous decisions. APA had signed onto an amicus brief last year in support of Moore with the American Academy of Psychiatry and the Law, AmericanRead More

[Continue reading…]

Multipronged study of schizophrenia-associated syndrome receives $3.1 million NIH grant

A research team at Emory University is embarking on a multipronged study of 3q29 deletion syndrome, a genetic mutation associated with a 40-fold increased risk for schizophrenia and a range of other neuropsychiatric conditions including mild to moderate intellectual disability, autism and anxiety. The research is funded by a $3.1 million grant from the NationalRead More

[Continue reading…]